| PubChem CID 66550890 ChemSpider 28536138 3D model (Jmol) Interactive image | PubChem SID 152143555 Formula C26H26F6N4O3 Molar mass 556.5 g/mol | |
 | ||
New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, and colon cancers and leukemia. The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012, and it currently being studied in clinical trials.
References
BMS-906024 Wikipedia(Text) CC BY-SA